Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
This study is currently recruiting participants.
Verified February 2013
by Otsuka Pharmaceutical Development & Commercialization, Inc.
Study NCT01418352 Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.
First Received on August 1, 2011. Last Updated on February 22, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Basal Ganglia Diseases
Central Nervous System Diseases
Genetic Diseases, Inborn
Heredodegenerative Disorders, Nervous System
Mental Disorders Diagnosed in Childhood
Nervous System Diseases
Interventions listed in this trial
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
Physiological Effects of Drugs
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers